TAK-593
目录号: A13555
VEGFR/PDGFR 抑制剂
TAK-593 是一种口服制剂,含有一种小分子受体酪氨酸激酶抑制剂,能够抑制血管内皮生长因子受体(VEGFR)和血小板衍生生长因子受体(PDGFR),具有潜在的抗肿瘤活性。
Discription | TAK-593 is an oral formulation containing a small-molecule receptor tyrosine kinase inhibitor of both vascular endothelial growth factor receptor (VEGFR) and platelet-derived growth factor receptor (PDGFR) with potential antineoplastic activity. | |||||
---|---|---|---|---|---|---|
Targets |
|
|||||
Cell Research |
|
目录号 | A13555 |
---|---|
分子式 | C23H23N7O3 |
分子量 | 445.47382 |
CAS号 | 1005780-62-0 |
SMILES | CC1=C(C=C(C=C1)OC2=NN3C=C(N=C3C=C2)NC(=O)C4CC4)NC(=O)C5=CC(=NN5C)C |
其他名称 | TAK593, TAK 593 |
储存条件 | Store lyophilized at -20ºC, keep desiccated. |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2